Clinical manifestations of the release of histamine and other inflammatory mediators

Journal of Allergy and Clinical Immunology

Volumn 103, Issue 3 SUPPL., 1999, Pages

  Naclerio, Robert ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGIC REACTION; ALLERGY; HISTAMINE RELEASE; HUMAN; INFLAMMATION; NOSE CONGESTION; PRIORITY JOURNAL; PRURITUS; REVIEW; RHINORRHEA; SEASONAL VARIATION; SNEEZING;

HISTAMINE RELEASE; HUMANS; INFLAMMATION MEDIATORS; RHINITIS, ALLERGIC, SEASONAL;

EID: 0032977062     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(99)70216-2     Document Type: Article

References (42)

1. Naclerio RM. Allergic rhinitis. N Engl J Med 1991;325:860-9.
2. Druce HM, Kaliner MA. Allergic rhinitis. JAMA 1988;259:260-3.
3. Levenson T, Greenberger PA. Pathophysiology and therapy for allergic and nonallergic rhinitis: an updated review. Allergy Asthma Proc 1997;8:213-20.
4. Howarth PH. The cellular basis for allergic rhinitis. Allergy 1995; 50(Suppl 23):6-10.
5. Naclerio R, Solomon W. Rhinitis and inhalent allergens. JAMA 1997; 278:1842-8.
6. Iliopoulos O, Proud D, Adkinson NF Jr, Norman PS, Kagey-Sobotka A, Lichtenstein LM, et al. Relationship between the early, late, and rechallenge reaction to nasal challenge with antigen: observations on the role of inflammatory mediators and cells. J Allergy Clin Immunol 1990; 86:851-61.
7. Meltzer EO. The pharmacological basis for the treatment of perennial allergic rhinitis and non-allergic rhinitis with topical corticosteroids. Allergy 1997;52(Suppl 36):33-40.
8. Naclerio RM, Lichtenstein LM, Kagey-Sobotka A, Proud D. Origin of late phase histamine release. J Allergy Clin Immunol 1996;98:721-3.
9. Bousquet J, Chanez P, Michel FB. Pathophysiology and treatment of seasonal allergic rhinitis. Respir Med 1990;84(Suppl A):11-7.
10. Naclerio RM. Pathophysiology of perennial allergic rhinitis. Allergy 1997:52(Suppl 36):7-13.
11. Wagenmann M, Baroody FM, Kagey-Sobotka A, Lichtenstein L, Naclerio RM. The effect of terfenadine on unilateral nasal challenge with allergen. J Allergy Clin Immunol 1994;93:594-605.
12. Gronborg H, Bisgaard H, Romeling F, Mygind N. Early and late nasal symptom response to allergen challenge. Allergy 1993;48:87-93.
13. Naclerio RM. Embryology, anatomy, and physiology of the upper airway. In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW, editors. Allergy: principles and practice. 4th ed. St Louis (MO): Mosby; 1993. p. 740-59.
14. Mygind N, Dahl R. Challenge tests in nose and bronchi: pharmacological modulation of rhinitis and asthma. Clin Exp Allergy 1996;26 (Suppl 3):39-43.
15. White MV, Kaliner MA. Mediators of allergic rhinitis. J Allergy Clin Immunol 1992;90:699-704.
16. Doyle WJ, Boehm S, Skoner DP. Physiologic responses to intranasal dose-response challenges with histamine, methacholine, bradykinin, and prostaglandin in adult volunteers with and without nasal allergy. J Allergy Clin Immunol 1990;86:924-35.
17. Svensson C, Baumgarten CR, Pipkorn U, Alkner U, Persson CGA. Reversibility and reproducibility of histamine induced plasma leakage in nasal airways. Thorax 1989;44:13-8.
18. Riccio MM, Reynolds CJ, Hay DW, Proud D. Effects of intranasal administration of endothelin-1 to allergic and nonallergic individuals. Am J Respir Crit Care Med 1995;152(6Pt1):1757-64.
19. Schleimer RP, MacGlashan DW, Gillepsie E, Lichtenstein LM. Inhibition of basophil histamine release by anti-inflammatory steroids. J Immunol 1982;129:1632-6.
20. Cohan VL, Undem BJ, Fox CC, Adkinson NF, Lichtenstein LM, Schleimer RP. Dexamethasone does not inhibit the release of mediators from human mast cells residing in airway, intestine, or skin. Am Rev Respir Dis 1989;140:951-4.
21. Mygind N, Dahl R. The rationale for the use of topical corticosteroids in allergic rhinitis. Clin Exp Allergy 1996;26(Suppl 3):2-10.
22. Holbrook KA, Pincus S, Parker F, Hollway GA Jr, Kraning KK, Yancey KB, et al. Structure, function, and immunology of the skin. In: Middleton EM Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW, editors. Allergy: principles and practice. 4th ed. St Louis (MO): Mosby; 1993. p. 390-427.
23. Monroe EW, Daly AF, Shalhoub RF. Apparaisal of the validity of histamine-induced wheal and flare to predict the efficacy of antihistamines. J Allergy Clin Immunol 1997;99:S798-806.
24. White MV. The role of histamine in allergic diseases. J Allergy Clin Immunol 1990;86:599-605.
25. 1 antihistamine, inhibits histamine release in vivo in man. Am Rev Respir Dis 1990;142:167-71.
26. Davies RJ, Bagnall AC, McCabe RN, Calderon MA, Wang JH. Antihistamines: topical vs oral administration. Clin Exp Allergy 1996;26:11-7.
27. Rachelefsky G. Childhood asthma and allergic rhinitis: the role of leukotrienes. J Pediatr 1997;131:348-55.
28. Okuda M, Watase T, Mezawa A, Liu CM. The role of leukotriene D4 in allergic rhinitis. Ann Allergy 1988;60:537-40.
29. Djukanovic R, Wilson SJ, Howarth PH. Pathology of rhinitis and bronchial asthma. Clin Exper Allergy 1996;26:44-51.
30. Proud D, Reynolds CJ, Lacapra S, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. Nasal provocation with bradykinin induces symptoms of rhinitis and a sore throat. Am Rev Respir Dis 1988;137:613-6.
31. Proud D. Kinins in the pathogeneses of human airway diseases. Braz J Med Biol Res 1994;27:2021-31.
32. Howarth PH. Mediators of nasal blockage in allergic rhinitis. Allergy 1997;52(Suppl 40):12-8.
33. Nomura Y, Matsura T. Distribution and clinical significance of the autonomic nervous system in the human nasal mucosa. Acta Otolaryngol 1972;73:493-501.
34. Knapp HR, Murray JJ. Leukotrienes as mediators of nasal inflammation. Adv Prostaglandin Thromboxane Leukot Res 1994;22:279-87.
35. Naclerio RM, Baroody FM, Togias AG. The role of leukotrienes in allergic rhinitis: a review. Am Rev Respir Dis 1991;143:S91-S95.
36. Knapp HR. Reduced allergen-induced nasal congestion and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor. N Engl J Med 1990;323:1745-8.
37. Donnelly AL, Glass M, Minkwitz MC, Casale TB. The leukotriene D4receptor antagonist, ICI 204,219, relieves symptoms of acute seasonal allergic rhinitis. Am J Respir Crit Care Med 1995;151:1734-9.
38. Rajakulasingam K, Polosa R, Lau LCK, Chruch MK, Holgate ST, Howarth PH. Comparative nasal effects of bradykinin and histamine: influence on nasal airways resistance and plasma protein exudation. Thorax 1993;48:324-9.
39. Baraniuk J, Lundgren JD, Mizoguchi H, Peden D, Gawin A, Merida M, et al. Bradykinin and respiratory mucous membranes. Am Rev Respir Dis 1990;141:706-14.
40. Devillier P, Dessanges JK, Rakatosihanaka JF. Nasal response to substance P and methacholine in subjects with or without allergic rhinitis. Eur Respir J 1988;1:356-61.
41. Fajac I, Braunstein G, Ickovic MR, Lacronique J, Frossard N. Selective recruitment of eosinophils by substance P after repeated allergen exposure in allergic rhinitis. Allergy 1995;50:970-5.
42. Okamoto Y, Shirotori K, Kudo K, Kazuo I, Ito E, Togawa K, et al. Cytokine expression after the topical administration of substance P to human nasal mucosa: the role of substance P in nasal allergy. J Immunol 1993;151:4391-8.